Evidence map›Paper›PMID 36713907›Full record

ArticleFrontiers in psychiatry2022

Performance evaluation of automated white matter hyperintensity segmentation algorithms in a multicenter cohort on cognitive impairment and dementia.

Malo Gaubert, Andrea Dell'Orco, Catharina Lange, Antoine Garnier-Crussard, Isabella Zimmermann, Martin Dyrba, Marco Duering, Gabriel Ziegler, Oliver Peters, Lukas Preis and 27 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 13 institutions in 5 countries.

Malo GaubertGerman Center for Neurodegenerative Diseases, Dresden, Germany.
Andrea Dell'OrcoGerman Center for Neurodegenerative Diseases, Dresden, Germany.
Catharina LangeGerman Center for Neurodegenerative Diseases, Dresden, Germany.
Antoine Garnier-CrussardClinical and Research Memory Center of Lyon, Lyon Institute for Elderly, Hospices Civils de Lyon, Lyon, France.
Isabella ZimmermannGerman Center for Neurodegenerative Diseases, Dresden, Germany.
Martin DyrbaGerman Center for Neurodegenerative Diseases, Rostock, Germany.
Marco DueringDepartment of Biomedical Engineering, Medical Image Analysis Center (MIAC) and qbig, University of Basel, Basel, Switzerland.
Gabriel ZieglerGerman Center for Neurodegenerative Diseases, Magdeburg, Germany.
Oliver PetersGerman Center for Neurodegenerative Diseases, Berlin, Germany.
Lukas PreisDepartment of Psychiatry, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Josef PrillerGerman Center for Neurodegenerative Diseases, Berlin, Germany.
Eike Jakob SpruthGerman Center for Neurodegenerative Diseases, Berlin, Germany.
Anja SchneiderGerman Center for Neurodegenerative Diseases, Bonn, Germany.
Klaus FliessbachGerman Center for Neurodegenerative Diseases, Bonn, Germany.
Jens WiltfangGerman Center for Neurodegenerative Diseases, Göttingen, Germany.
Björn H SchottGerman Center for Neurodegenerative Diseases, Göttingen, Germany.
Franziska MaierDepartment of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany.
Wenzel GlanzGerman Center for Neurodegenerative Diseases, Magdeburg, Germany.
Katharina BuergerGerman Center for Neurodegenerative Diseases, Munich, Germany.
Daniel JanowitzDepartment of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich (LMU), Munich, Germany.
Robert PerneczkyGerman Center for Neurodegenerative Diseases, Munich, Germany.
Boris-Stephan RauchmannDepartment of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University of Munich (LMU), Munich, Germany.
Stefan TeipelGerman Center for Neurodegenerative Diseases, Rostock, Germany.
Ingo KilimannGerman Center for Neurodegenerative Diseases, Rostock, Germany.
Christoph LaskeGerman Center for Neurodegenerative Diseases, Tübingen, Germany.
Matthias H MunkGerman Center for Neurodegenerative Diseases, Tübingen, Germany.
Annika SpottkeGerman Center for Neurodegenerative Diseases, Bonn, Germany.
Nina RoyGerman Center for Neurodegenerative Diseases, Bonn, Germany.
Laura DobischGerman Center for Neurodegenerative Diseases, Magdeburg, Germany.
Michael EwersGerman Center for Neurodegenerative Diseases, Munich, Germany.
Peter DechentMR-Research in Neurosciences, Department of Cognitive Neurology, Georg-August-University of Göttingen, Göttingen, Germany.
John Dylan HaynesBernstein Center for Computational Neuroscience, Charité - Universitätsmedizin, Berlin, Germany.
Klaus SchefflerDepartment for Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany.
Emrah DüzelGerman Center for Neurodegenerative Diseases, Magdeburg, Germany.
Frank JessenGerman Center for Neurodegenerative Diseases, Bonn, Germany.
Miranka WirthGerman Center for Neurodegenerative Diseases, Dresden, Germany.
DELCODE study group
German Center for Neurodegenerative Diseases · DELudwig-Maximilians-Universität München · DECharité - Universitätsmedizin Berlin · DEUniversity of Bonn · DEUniversity of Tübingen · DELeibniz Institute for Neurobiology · DEUniversité Claude Bernard Lyon 1 · FRUniversity of Aveiro · PTUniversity of Basel · CHUniversity of Cologne · DEUniversity of Edinburgh · GBUniversity of Göttingen · DEUniversity of Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: White matter hyperintensities (WMH), a biomarker of small vessel disease, are often found in Alzheimer's disease (AD) and their advanced detection and quantification can be beneficial for research and clinical applications. To investigate WMH in large-scale multicenter studies on cognitive impairment and AD, appropriate automated WMH segmentation algorithms are required. This study aimed to compare the performance of segmentation tools and provide information on their application in multicenter research. Methods: We used a pseudo-randomly selected dataset ( Results: Across tools, segmentation performance was moderate for global WMH volume and number of detected lesions. After retraining on a DELCODE subset, the deep learning algorithm sysu_media showed the highest performances with an average Dice's coefficient of 0.702 (±0.109 SD) for volume and a mean F1-score of 0.642 (±0.109 SD) for the number of lesions. The intra-class correlation was excellent for all algorithms (>0.9) but BIANCA (0.835). Performance improved with high WMH burden and varied across brain regions. Conclusion: To conclude, the deep learning algorithm, when retrained, performed well in the multicenter context. Nevertheless, the performance was close to traditional methods. We provide methodological recommendations for future studies using automated WMH segmentation to quantify and assess WMH along the continuum of cognitive impairment and AD dementia.

Indexed as

agingAlzheimer’s diseasedeep learningevaluationFLAIRwhite matter hyperintensities segmentation

Identifiers

PMID36713907
PMCPMC9877422
OpenAlexW4315781299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.